Myositis Activities Profile

Known as: MAP 
An assessment of disease-specific limitations of activities of daily living in patients with polymyositis and dermatomyositis.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1969-2017
024619692017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
It has been suggested that passive shedding of Mycobacterium avium subsp. paratuberculosis (MAP) in faeces may occur, but… (More)
Is this relevant?
2012
2012
OBJECTIVE To evaluate some measurement properties of the Myositis Activities Profile (MAP) in adult patients with polymyositis… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2012
2012
To establish environmental contamination in and around a dairy barn, cows shedding Mycobacterium avium ssp. paratuberculosis (MAP… (More)
Is this relevant?
2011
2011
Despite the increasing evidence of MAP/DNA isolation in Crohn’s disease (CD), its potential pathogenetic role remains unclear. To… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2004
2004
When ovulation is induced with gonadotrophin-releasing hormone (GnRH) in anoestrous ewes, a proportion of animals fail to form… (More)
Is this relevant?
2002
2002
OBJECTIVE To develop a disease-specific questionnaire for assessing limitations in activities of daily life, the Myositis… (More)
Is this relevant?
2000
2000
The objectives of this study were to determine residual and absorbed levels of medroxyprogesterone acetate (MAP) after treatment… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
1995
1995
OBJECTIVE Recently, it has been shown that the inhalation of nitric oxide (NO) and of prostacyclin (PGI2) elicits selective… (More)
Is this relevant?
1994
1994
Methamphetamine (MAP: 1 and 2 mg/kg SC) and caffeine (CAF: 1, 3, 10 and 30 mg/kg SC) dose-dependently increased ambulation in… (More)
  • table 1
  • figure 2
  • figure 1
  • table 2
Is this relevant?
1978
1978
The results obtained with a new hormone therapy using medroxyprogesterone acetate (MAP) in previously untested single and total… (More)
Is this relevant?